FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 137 filers reported holding FIBROGEN INC in Q3 2016. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $734,000 | -16.9% | 16,241 | 0.0% | 0.06% | -29.8% |
Q1 2019 | $883,000 | -32.9% | 16,241 | -42.9% | 0.08% | -22.2% |
Q4 2018 | $1,316,000 | +138.8% | 28,429 | +213.6% | 0.11% | +163.4% |
Q3 2018 | $551,000 | +10.6% | 9,065 | +14.0% | 0.04% | -2.4% |
Q2 2018 | $498,000 | -52.8% | 7,952 | -65.2% | 0.04% | -44.0% |
Q1 2018 | $1,055,000 | -16.5% | 22,835 | -14.3% | 0.08% | -33.0% |
Q4 2017 | $1,263,000 | +69.3% | 26,642 | +15.4% | 0.11% | +33.3% |
Q2 2017 | $746,000 | +31.1% | 23,081 | 0.0% | 0.08% | +50.0% |
Q1 2017 | $569,000 | -62.8% | 23,081 | -75.3% | 0.06% | -72.3% |
Q2 2016 | $1,531,000 | -27.6% | 93,295 | -6.0% | 0.20% | -20.8% |
Q1 2016 | $2,114,000 | +425.9% | 99,295 | +652.2% | 0.26% | +410.0% |
Q4 2015 | $402,000 | +13.2% | 13,200 | -18.5% | 0.05% | +4.2% |
Q3 2015 | $355,000 | – | 16,200 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |